Evidence map›Paper›PMID 35332007›Full record

ArticleBMJ case reports2022

Thrombotic thrombocytopenic purpura following administration of the Moderna booster vaccine.

Emma Herrman, Bipin Ghimire, Mohammad Muhsin Chisti

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 63% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Emma HerrmanInternal Medicine, Beaumont Health, Royal Oak, Michigan, USA emma.herrman@beaumont.org.
Bipin GhimireInternal Medicine, Beaumont Health, Royal Oak, Michigan, USA.
Mohammad Muhsin ChistiHematology and Medical Oncology, Oakland University William Beaumont School of Medicine, Troy, Michigan, USA.ORCID http://orcid.org/0000-0002-2676-9577
Beaumont Health · USOakland University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thrombotic thrombocytopenic purpura (TTP) is a type of thrombotic microangiopathy that is characterized by microangiopathic haemolytic anaemia, consumption thrombocytopenia and organ injury. It is caused by a severe deficiency of ADAMTS13, which can be either congenital or acquired. There is a plethora of things that can cause the acquired form, including medications and infections. Vaccines have also been shown to cause TTP. In the midst of the COVID-19 pandemic, with multiple new vaccines being developed and distributed to the masses, the medical community needs to be aware of adverse events associated with these new vaccines. We present a case of TTP following administration of the Moderna booster vaccine.

Indexed as

Anemia, HemolyticCOVID-19Purpura, Thrombotic ThrombocytopenicHumansImmunization, SecondaryPandemicsCOVID-19haematology (incl blood transfusion)immunological products and vaccinesmalignant and benign haematology

Identifiers

PMID35332007
PMCPMC8948389
OpenAlexW4220734322

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.